tiprankstipranks
Trending News
More News >
Advertisement

FDV - ETF AI Analysis

Compare

Top Page

FDV

Federated Hermes U.S. Strategic Dividend ETF (FDV)

Rating:72Outperform
Price Target:
FDV, the Federated Hermes U.S. Strategic Dividend ETF, appears to be a solid, income-focused fund supported by strong core holdings like Amgen, Paychex, Prologis, and US Bancorp, which all benefit from healthy financial performance, positive earnings commentary, and, in several cases, attractive dividends and growth initiatives. However, some holdings such as Evergy and AbbVie face issues like weaker revenue or cash flow trends, leverage, and valuation concerns, which likely temper the fund’s overall rating. The main risk factor is that several key positions show bearish or mixed technical signals and financial pressures, which could add volatility even though the portfolio is diversified across sectors.
Positive Factors
Solid Recent Performance
The ETF has shown steady gains over the past month, three months, and year-to-date, indicating positive recent momentum.
Strong Top Holdings
Most of the largest positions, including major financial, energy, and utility names, have delivered strong or steady performance, supporting the fund’s returns.
Diversified Defensive Sector Mix
Significant exposure to utilities, consumer defensive, health care, and real estate can provide a more stable income-oriented profile compared with more growth-heavy funds.
Negative Factors
Moderately High Expense Ratio
The fund’s expense ratio is on the higher side for an ETF, which can gradually reduce net returns for long-term investors.
Heavy U.S.-Only Exposure
With almost all assets in U.S. companies, the ETF offers little geographic diversification and is highly tied to the U.S. market and economy.
Sector Concentration in Utilities and Financials
Large weights in utilities and financials mean the fund could be more sensitive to interest rate changes and sector-specific downturns.

FDV vs. SPDR S&P 500 ETF (SPY)

FDV Summary

Federated Hermes U.S. Strategic Dividend ETF (FDV) is a U.S.-focused fund that aims to pay investors steady income by owning stocks with relatively high dividend payments. It doesn’t track a set index, but instead selects a mix of solid, dividend-paying companies across many sectors, including utilities, banks, health care, and consumer staples. Well-known holdings include Chevron and Amgen. Someone might invest in FDV for a combination of income and potential long-term growth, while getting diversification across many industries. A key risk is that stock prices and dividend payments can go up and down with the market.
How much will it cost me?The Federated Hermes U.S. Strategic Dividend ETF (FDV) has an expense ratio of 0.50%, meaning you’ll pay $5 per year for every $1,000 invested. This is slightly higher than average because it is actively managed, focusing on selecting high-dividend U.S. stocks with strong fundamentals. Active management typically involves more research and decision-making, which can increase costs.
What would affect this ETF?The Federated Hermes U.S. Strategic Dividend ETF could benefit from stable or declining interest rates, which often make dividend-paying stocks more attractive, as well as continued strength in defensive sectors like Utilities and Health Care that dominate its portfolio. However, rising interest rates or economic uncertainty could negatively impact dividend-paying companies, particularly in sectors like Real Estate and Financials, which are sensitive to borrowing costs and market volatility.

FDV Top 10 Holdings

FDV leans heavily into classic dividend payers, with U.S. utilities, financials, and health care names setting the tone. PNC Financial and U.S. Bancorp have been rising, giving the fund a helpful tailwind from the banking corner, while Chevron’s rebound in energy and Amgen’s steady climb in pharma add more fuel to returns. On the flip side, Paychex has been dragging the fund lately, and AbbVie’s more mixed performance keeps health care from fully shining. Overall, this is a U.S.-centric, income-first portfolio with a few laggards but plenty of sturdy workhorses.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
Paychex4.40%$26.96M$35.32B-34.36%
77
Outperform
AbbVie3.69%$22.65M$410.83B8.43%
66
Neutral
PNC Financial3.63%$22.28M$85.66B14.66%
71
Outperform
Chevron3.49%$21.42M$378.92B21.49%
71
Outperform
US Bancorp3.34%$20.47M$83.76B20.55%
76
Outperform
Amgen3.29%$20.16M$198.16B13.75%
77
Outperform
Evergy2.99%$18.31M$19.09B26.12%
62
Neutral
Prologis2.90%$17.76M$131.14B12.20%
76
Outperform
WEC Energy Group2.86%$17.54M$37.79B8.66%
67
Neutral
CME Group2.78%$17.08M$113.62B24.56%
74
Outperform

FDV Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price
Price Trends
50DMA
30.33
Positive
100DMA
29.28
Positive
200DMA
28.40
Positive
Market Momentum
MACD
0.33
Positive
RSI
50.74
Neutral
STOCH
8.43
Positive
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For FDV, the sentiment is Neutral. The current price of undefined is equal to the 20-day moving average (MA) of 31.68, equal to the 50-day MA of 30.33, and equal to the 200-day MA of 28.40, indicating a neutral trend. The MACD of 0.33 indicates Positive momentum. The RSI at 50.74 is Neutral, neither overbought nor oversold. The STOCH value of 8.43 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for FDV.

FDV Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$616.65M0.50%
72
Outperform
$226.88M0.59%
68
Neutral
$167.11M0.49%
69
Neutral
$154.87M0.35%
72
Outperform
$73.43M0.35%
71
Outperform
$29.95M0.45%
70
Neutral
Performance Comparison
Ticker
Company Name
Price
Change
% Change
FDV
Federated Hermes U.S. Strategic Dividend ETF
31.25
3.62
13.10%
TBG
TBG Dividend Focus ETF
ELCV
Eventide High Dividend ETF
HIDV
AB US High Dividend ETF
FDIV
MarketDesk Focused U.S. Dividend ETF
DIVY
Sound Equity Income ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement